Claritev Corporation (CTEV) vs National Research Corporation (NRC)
Claritev Corporation and National Research Corporation are both Health Information Services companies. National Research Corporation is the larger, with a market value of $450.1M against $395.9M — 1.1× the size. Claritev Corporation has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 78.3×. Claritev Corporation grew revenue faster over the last twelve months: 6.32% against −0.23%. National Research Corporation has the higher net margin (3.96% vs −28.5%) and the higher return on invested capital (10.3% vs 0.47%). Across the 19 metrics below, Claritev Corporation leads on 10 and National Research Corporation on 9.
Valuation
Profitability
| Metric | CTEV | NRC | Health Information Services median |
|---|---|---|---|
| Gross margin | 72.97% | 61.75% | 63.38% |
| Operating margin | 3.27% | 10.53% | (8.35%) |
| Net margin | (28.46%) | 3.96% | (14.70%) |
| Free cash flow margin | (1.80%) | 15.46% | 0.58% |
| Return on equity | 172.76% | 39.82% | (6.82%) |
| Return on assets | (5.76%) | 4.00% | (6.02%) |
| Return on invested capital | 0.47% | 10.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack